BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 19248550)

  • 1. Clinical significance of reporting benign-appearing endometrial cells in Pap tests in women aged 40 years and over.
    Jones E; Frain BM; Crabtree W
    Acta Cytol; 2009; 53(1):18-23. PubMed ID: 19248550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Bethesda System 2001 recommendation for reporting of benign appearing endometrial cells in Pap tests of women age 40 years and older leads to unwarranted surveillance when followed without clinical qualifiers.
    Aslan DL; Crapanzano JP; Harshan M; Erroll M; Vakil B; Pirog EC
    Gynecol Oncol; 2007 Oct; 107(1):86-93. PubMed ID: 17604086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of cytologically normal endometrial cells in cervical smears from postmenopausal women.
    Sarode VR; Rader AE; Rose PG; Rodriguez M; Abdul-Karim FW
    Acta Cytol; 2001; 45(2):153-6. PubMed ID: 11284298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical relevance of benign endometrial cells in postmenopausal women.
    Ashfaq R; Sharma S; Dulley T; Saboorian MH; Siddiqui MT; Warner C
    Diagn Cytopathol; 2001 Oct; 25(4):235-8. PubMed ID: 11599107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significant increase of benign endometrial cells on Papanicolaou smears in women using hormone replacement therapy.
    Mount SL; Wegner EK; Eltabbakh GH; Olmstead JI; Drejet AE
    Obstet Gynecol; 2002 Sep; 100(3):445-50. PubMed ID: 12220762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Papanicolaou smears, benign appearing endometrial cells bear no significance in predicting uterine endometrial adenocarcinomas.
    Moatamed NA; Le LT; Levin MR; Govind R; Apple SK
    Diagn Cytopathol; 2013 Apr; 41(4):335-41. PubMed ID: 22102567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normal-Appearing Endometrial Cells in Pap Tests of Women Aged Forty Years or Older and Cytohistological Correlates.
    Izadi-Mood N; Sarmadi S; Sanii S; Sadidi H
    Acta Cytol; 2015; 59(2):175-9. PubMed ID: 25924690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytologically benign endometrial cells in the papanicolaou smears of postmenopausal women.
    Chang A; Sandweiss L; Bose S
    Gynecol Oncol; 2001 Jan; 80(1):37-43. PubMed ID: 11136567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Classification of benign endometrial glandular cells in cervical smears from postmenopausal women.
    Brogi E; Tambouret R; Bell DA
    Cancer; 2002 Apr; 96(2):60-6. PubMed ID: 11954022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of benign endometrial cells in Pap smears from postmenopausal women.
    Wu HH; Schuetz MJ; Cramer H
    J Reprod Med; 2001 Sep; 46(9):795-8. PubMed ID: 11584479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Clinical Significance of Endometrial Cells Detected on Pap Testing: The Impact of Revisions to the 3rd Edition of the Bethesda System for Reporting Cervical Cytology.
    Morikawa LH; Tauchi-Nishi PS
    Ann Clin Lab Sci; 2017 May; 47(3):298-305. PubMed ID: 28667030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The significance of atypical glandular cells on routine cervical cytologic testing in a community-based population.
    Chin AB; Bristow RE; Korst LM; Walts A; Lagasse LD
    Am J Obstet Gynecol; 2000 Jun; 182(6):1278-82. PubMed ID: 10871439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical glandular cells of undetermined significance favor endometrial origin. Criteria for separating low grade endometrial adenocarcinoma from benign endometrial lesions.
    Salomão DR; Hughes JH; Raab SS
    Acta Cytol; 2002; 46(3):458-64. PubMed ID: 12040637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrauterine pathology in women with abnormal uterine bleeding taking hormone replacement therapy.
    Leung PL; Tam WH; Kong WS; Yuen PM
    J Am Assoc Gynecol Laparosc; 2003 May; 10(2):260-2. PubMed ID: 12732781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of benign endometrial cells in papanicolaou tests from women aged >or=40 years.
    Thrall MJ; Kjeldahl KS; Savik K; Gulbahce HE; Pambuccian SE
    Cancer; 2005 Aug; 105(4):207-16. PubMed ID: 15900572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reporting normal endometrial cells in Pap smears: an outcome appraisal.
    Gomez-Fernandez CR; Ganjei-Azar P; Capote-Dishaw J; Averette HE; Nadji M
    Gynecol Oncol; 1999 Sep; 74(3):381-4. PubMed ID: 10479497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of endometrium of patients with abnormal uterine bleeding at Chitwan Valley.
    Dangal G
    Kathmandu Univ Med J (KUMJ); 2003; 1(2):110-2. PubMed ID: 16388208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and clinical significance of morphologically benign-appearing endometrial cells in patients age 40 years or older: the impact of the 2001 Bethesda System.
    Bean SM; Connolly K; Roberson J; Eltoum I; Chhieng DC
    Cancer; 2006 Feb; 108(1):39-44. PubMed ID: 16329117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative Predictive Value and Significance of Benign-Appearing Endometrial Cells in Papanicolaou Tests.
    Yu J; Onisko A; Austin RM
    Am J Clin Pathol; 2017 Sep; 148(3):274-279. PubMed ID: 28821196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rebleeding and endometrial growth in women with postmenopausal bleeding and endometrial thickness < 5 mm managed by dilatation and curettage or ultrasound follow-up: a randomized controlled study.
    Epstein E; Valentin L
    Ultrasound Obstet Gynecol; 2001 Nov; 18(5):499-504. PubMed ID: 11844172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.